Rise of Biologics
SESSION 2. Rise of Biologics
Biologic therapies have significantly transformed patient care, especially in oncology, immunology, and rare diseases. This discussion will focus on the latest advancements in biologics, including the development of monoclonal antibodies and breakthroughs in gene therapy. Challenges in biologic drug development and the emergence of biosimilar will also be examined, along with the potential of combination therapies to enhance treatment efficacy.
Sub-Sessions:
Track 2-1 Monoclonal Antibodies in Disease Treatment
Track 2-2 Gene Therapy Breakthroughs
Track 2-3 Biosimilars: The Future of Biologics
Track 2-4 Biologic Drug Development Challenges
Track 2-5 Biologic Combination Therapies